GlassScriptPhysician profile
Sunny Gupta
NPI 1306097332
$9,992.50
in general payments reported to CMS, 2019-2025
13 companies · $380 in 2025
The $380 reported for 2025 was more than what 79% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,203 · 2020: $1,860 · 2021: $1,928 · 2022: $3,169 · 2023: $1,220 · 2024: $233 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043 · Consulting Fee: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,043.23 |
| Consulting Fee | $790.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $4,100.61 | 2019-2025 | Euflexxa |
| Lilly USA, LLC | $1,750.00 | 2020 | |
| Stryker Corporation | $1,576.30 | 2021 | |
| Arthrex, INC. | $1,127.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $759.94 | 2021-2025 | Gel-One Cross-Linked Hyaluronate |
| Pacira Pharmaceuticals Incorporated | $142.37 | 2023 | Iovera |
| Horizon Therapeutics Plc | $139.62 | 2020-2021 | |
| Depuy Synthes Sales INC. | $136.31 | 2019-2025 | Orthovisc, Monovisc |
| Edwards Lifesciences Corporation | $126.57 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Bioventus LLC | $57.43 | 2022 | |
| Ucb, INC. | $39.85 | 2022 | |
| Avanos Medical | $20.39 | 2022 | |
| Fidia Pharma USA INC. | $16.11 | 2025 | Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunny Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.